John Buza, MD
Orthopaedic Surgery of the Spine · Fresh Meadows, NYNPI 1760827976
Payments from drug & device makers
Across 88 payments — averaging $80.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medtronic$2K
- Globus Medical$2K
- Medical Device Business Services, Inc.$862
- Spineology Inc.$234
- Acumed LLC$214
- plus $637 from 6 others
What the payments were for
- Travel & lodging$2,76839%
- Food & beverage$4,10458%
- Education$2203%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 14 | $1,822 |
| Medtronic(2 entities) | 39 | $1,813 |
| Globus Medical | 8 | $1,510 |
| Medical Device Business Services, Inc. | 9 | $862 |
| Spineology Inc. | 1 | $234 |
| Acumed LLC | 3 | $214 |
| Johnson & Johnson(2 entities) | 4 | $213 |
| Boston Scientific | 1 | $164 |
| Si-bone, Inc. | 1 | $122 |
| Orthofix Medical, Inc. | 6 | $83 |
| Titan Spine, LLC | 1 | $36 |
| Exactech, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XLIF$1,228
- MAKO$827
- EXPEDIUM$754
- CD HORIZON$432
- AVIATOR$286
- ESCALATE$286
- XIA$286
- ES2$286
- OASYS$286
- OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM$234
- GAMMA$165
- CASCADIA$149
- ACUMED$146
- InFrame Implant$146
- KYPHON EXPRESS II KYPHOPAK TRAY$134
- iFuse Implant$122
- NONE$116
- SYMPHONY$106
How this compares
$7,092 in reported general payments places this provider in the 40th percentile of 161 orthopaedic surgery of the spine providers in New York.
See all orthopaedic surgery of the spine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 160 | $5,361 |
| Tizanidine Hcl | 302 | $2,500 |
| Gabapentin | 201 | $1,383 |
| Methocarbamol | 38 | $454 |
| Cyclobenzaprine Hcl | 58 | $390 |
| Oxycodone Hcl | 39 | $246 |
| Ibuprofen | 21 | $80 |
| Tramadol Hcl | 21 | $66 |
| Meloxicam | 11 | $41 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Fresh Meadows
- Hansen YuanSyracuse$31.7M
- Frank CammisaNew York$6.2M
- Frank SchwabNew York$5.1M
- Han KimNew York$4M
- Todd AlbertNew York$3M
- Jeffrey SpivakNew York$1.3M
- Aaron BucklandNew York$1.2M
- Andrew SamaNy$942K
- Sheeraz QureshiNew York$929K
- Seth NeubardtWhite Plains$902K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.